XSS in Bmc Remedy_mid-tier
CVE-2017-17678
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
Vulnerability class: XSS (Cross-Site Scripting)
EPSS: 0.008 (53.4th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 6.1 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N.
Affected products
- Bmc Remedy_mid-tier — versions 9.1
- N/a — versions n/a
Weakness classification (CWE)
References
- cve@mitre.org (Product, x_refsource_MISC)
- cve@mitre.org (Product, x_refsource_MISC)
- cve@mitre.org (x_refsource_MISC, Release Notes, Vendor Advisory)
- cve@mitre.org (Mailing List, Third Party Advisory, x_refsource_MISC)
Frequently asked questions
- What is CVE-2017-17678?
- CVE-2017-17678 is a medium-severity vulnerability in Bmc Remedy_mid-tier, classified under Cross-site Scripting. CVSS score: 6.1/10. Published 2021-05-19.
- How severe is CVE-2017-17678?
- Medium severity. CVSS v3 base score is 6.1 out of 10.